Cartesian Therapeutics (RNAC) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Cartesian Therapeutics (RNAC) Interest Coverage Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Cartesian Therapeutics | 226.07 Mn | 226.07 Mn | - | 67.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.17% |
| Dec 31, 2025 | 239.83% |
| Sep 30, 2025 | -258.32% |
| Jun 30, 2025 | -408.08% |
| Mar 31, 2025 | -6,465.17% |
| Dec 31, 2024 | -9,394.14% |
| Sep 30, 2024 | 88.74% |
| Jun 30, 2024 | 101.68% |
| Mar 31, 2024 | 95.38% |
| Dec 31, 2023 | 95.36% |
| Sep 30, 2023 | -414.76% |
| Jun 30, 2023 | -227.86% |
| Mar 31, 2023 | -249.29% |
| Dec 31, 2022 | -173.47% |
| Sep 30, 2022 | 28.01% |
| Jun 30, 2022 | 2,949.22% |
| Mar 31, 2022 | 251.35% |
| Dec 31, 2021 | 178.33% |
| Sep 30, 2021 | 92.64% |
| Jun 30, 2021 | 100.80% |